Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants

NCT07117669 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Peanut Allergy

Interventions

DRUG: ENP-501
DRUG: Placebo

Sponsor

N-Fold, LLC

Collaborators

[object Object]